contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


demant-as-investor-news-demant-opnar-regulatorisk-godkendelse-af-opkob-af-kind

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Demant operates in the medical technology sector. The company specializes in the development of hearing aids and hearing loops. The company operates on a global level where the products are sold under various brands. The products are available through the company's distributors and sales channels. In addition to its main business, the company conducts research in diagnostics for measuring hearing quality. The company was originally founded in 1904 and has its headquarters in Smörum.

Demant

19.11.2025 12:40:19 CET | Demant A/S | Investor NyhederInvestor news19. november 2025Demant opnår regulatorisk godkendelse af opkøb af KIND I juni 2025 meddelte Demant, at koncernen havde indg...

<p class="prs-announcement__byline">19.11.2025 12:40:19 CET | Demant A/S |    Investor Nyheder</p><table class="prs-table"><tbody><tr><td><p><strong>Investor news</strong></p></td><td><p><strong>19. november 2025</strong></p></td></tr></tbody></table><p><strong>Demant opnår regulatorisk godkendelse af opkøb af KIND</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>I juni 2025 meddelte Demant, at koncernen havde indgået en aftale om at opkøbe KIND Group (KIND), som er en af verdens førende forhandlere af høreapparater med omkring 650 høreklinikker. Pr. dags dato er alle regulatoriske betingelser opfyldt, hvilket omfatter godkendelser fra både de østrigske og tyske konkurrencemyndigheder.</p><p>&nbsp;</p><p>Da de regulatoriske betingelser nu er opfyldt, udestår der opfyldelse af sædvanlige betingelser, før parterne kan lukke transaktionen. Dette forventes at ske i begyndelsen af december 2025, hvor vi vil kunne give nærmere oplysninger om, hvilken økonomisk betydning integreringen af KIND i Demant vil få.</p><p>&nbsp;</p><p>&nbsp;</p><table class="prs-table"><tbody><tr><td><p><em>Yderligere information:</em></p><p>Søren Nielsen, koncernchef &amp; adm. direktør</p><p>Telefon +45 3917 7300</p><p><a href="http://www.demant.com">www.demant.com</a></p></td><td><p><em>Øvrige kontaktpersoner:</em></p><p>René Schneider, CFO</p><p>Peter Pudselykke, Head of Investor Relations</p><p>Gustav Høegh, Investor Relations Officer</p><p>Henrik Axel Lynge Buchter, Manager of External Communications</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><h4>Kontakter</h4><ul>    <li>        Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication &amp; Sustainability, +45 2264 9982, <a href="mailto:heey@demant.com">heey@demant.com</a>    </li></ul><h4>Om Demant A/S</h4><p>Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 22,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.</p><h4>Vedhæftninger</h4><ul>    <li>        <a href="https://via.ritzau.dk/ir-files/13560112/14683692/16620/Investor%20news%20-%20Demant%20opn%C3%A5r%20regulatorisk%20godkendelse%20af%20opk%C3%B8b%20af%20KIND.pdf">Investor news - Demant opnår regulatorisk godkendelse af opkøb af KIND.pdf</a>    </li></ul>

Demant A/S: Investor news - Demant opnår regulatorisk godkendelse af opkøb af KIND